The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

By Møller Pål   Stormorken Astrid   Holmen Marit   Hagen Anne   Vabø Anita   Mæhle Lovise  

Breast Cancer Research and Treatment, Vol. 144, Iss. 3, 2014-04 ,pp. : 607-614

Springer Publishing Company

Access to resources Recommend Favorite

Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from Western Sweden

By Einbeigi Zakaria   Bergman Annika   Meis-Kindblom Jeanne   Flodin Anna   Bjursell Cecilia   Martinsson Tommy   Kindblom Lars-Gunnar   Wahlström Jan   Wallgren Arne   Nordling Margareta   Karlsson Per  

Familial Cancer, Vol. 6, Iss. 1, 2007-03 ,pp. : 35-41

Springer Publishing Company

Access to resources Recommend Favorite

Heterogenic Loss of the Wild-Type BRCA Allele in Human Breast Tumorigenesis

By King Tari   Li Weiwei   Brogi Edi   Yee Cindy   Gemignani Mary   Olvera Narciso   Levine Douglas   Norton Larry   Robson Mark   Offit Kenneth   Borgen Patrick   Boyd Jeff  

Annals of Surgical Oncology, Vol. 14, Iss. 9, 2007-09 ,pp. : 2510-2518

Springer Publishing Company

Access to resources Recommend Favorite

Heterogenic Loss of BRCA in Breast Cancer: The “Two-Hit” Hypothesis Takes a Hit

By Meric-Bernstam Funda  

Annals of Surgical Oncology, Vol. 14, Iss. 9, 2007-09 ,pp. : 2428-2429

Springer Publishing Company

Access to resources Recommend Favorite

Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation

By Kim Dongwon   Kang Eunyoung   Hwang Euijun   Sun Young   Hwang Yoonsun   Yom Cha   Kim Kidong   No Jae   Kim Yong-Beom   Kim Sung-Won  

Familial Cancer, Vol. 12, Iss. 4, 2013-12 ,pp. : 621-628

Springer Publishing Company

Access to resources Recommend Favorite